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Abstract CHIP, carboxy terminus of Hsc70 interacting protein, is a cytoplasmic protein whose amino acid sequence
is highly conserved across species. It is most highly expressed in cardiac and skeletal muscle and brain. The primary
amino acid sequence is characterized by 3 domains, a tetratricopeptide repeat (TPR) domain at its amino terminus, a
U-box domain at its carboxy terminus, and an intervening charged domain. CHIP interacts with the molecular chap-
erones Hsc70-Hsp70 and Hsp90 through its TPR domain, whereas its U-box domain contains its E3 ubiquitin ligase
activity. Its interaction with these molecular chaperones results in client substrate ubiquitylation and degradation by the
proteasome. Thus, CHIP acts to tilt the folding-refolding machinery toward the degradative pathway, and it serves as
a link between the two. Because protein degradation is required for healthy cellular function, CHIP’s ability to degrade
proteins that are the signature of disease, eg, ErbB2 in breast and ovarian cancers, could prove to be a point of
therapeutic intervention.
INTRODUCTION
Proper protein folding is essential for optimum protein
performance and normal cellular function. The molecular
chaperones check and enable correct folding of nascent
polypeptides. By binding to exposed hydrophobic re-
gions, they allow or promote proper folding and the cor-
rect tertiary conformation. They are also required for pro-
tein ‘‘refolding’’ because proteins denature because of
age, stress, disease, and gene mutation.
During synthesis of new proteins and refolding of de-
natured proteins, cooperation between the cell’s molecu-
lar chaperones and its degradation machinery must occur
because some proteins cannot attain their correct tertiary
conformation spontaneously. The mutually exclusive
pathways of folding and degradation constitute the cell’s
protein quality control system. The choice between the 2
pathways has come to be known as ‘‘molecular triage’’
(Wickner et al 1999). The factors that influence this mo-
lecular triage decision are not clearly understood. Diffi-
culty with folding and, therefore, the time spent in a par-
tially folded conformation can influence the pathway cho-
sen. Other factors—such as age, disease, or stress—can
affect the fraction of unfolded proteins and, consequently,
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can affect the balance of protein ‘‘rescue’’ or protein deg-
radation. Whether this decision is a stochastic process or
a regulated and ordered process is also not clear.
To understand this issue, one benefits from looking at
the class of proteins called ‘‘molecular cochaperones.’’
This ever-growing clutch of proteins interacts directly
with chaperones such as Hsc70 and Hsp90 and modu-
lates their functions. The J-domain proteins such as Hsp40
are prototypical cochaperones that interact with Hsc70
and enhance adenosine triphosphatase (ATPase) activity
and folding reactions, and more recently, cochaperones
with other functions (such as conformational stabilization
and nucleotide exchange) have been identified. Recent ev-
idence indicates that another cochaperone, CHIP (carbox-
yl terminus of Hsc70 interacting protein), also regulates
chaperone function in part by regulating the molecular
triage decision and determining whether proteins enter
the productive folding pathway or the degradation path-
way.
Characterization of CHIP
Proteins containing tetratricopeptide repeat (TPR) do-
mains are involved in many protein-protein interactions
(Lamb et al 1995); in particular, several heat shock protein
interaction partners—including Hip, Hop, and the cyclo-
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Fig 1. The Hsc70 reaction cycle. This diagram depicts the rela-
tionship between Hsc70, its cochaperones, and nucleotide-depen-
dent folding properties of Hsc70.
philins—interact with Hsc70 or Hsp90 through TPR do-
mains (Ratajczak et al 1993; Hohfeld et al 1995; Demand
et al 1998). In an attempt to identify additional proteins
that might be involved in stress regulation, a human
heart complementary deoxyribonucleic acid (cDNA) li-
brary was screened with a fragment of cyclophilin-40
containing its 3 carboxy-terminal TPR domains (Ballinger
et al 1999). CHIP was identified through this screen. The
CHIP cDNA encodes a 34.5-kDa protein containing three
34-amino acid TPR domains at its amino terminus (Bal-
linger et al 1999) and a ‘‘U-box’’ domain at its carboxyl
terminus (Murata et al 2001). U-box domains are similar
to RING finger domains, but they lack the metal-chelating
residues and are thought to be structured by intramolec-
ular interactions (Aravind and Koonin 2000). The pre-
dicted structural similarity between RING fingers and U-
box domains suggests that U boxes, like RING fingers,
may also play a role in targeting proteins for ubiquity-
lation and subsequent proteasome-dependent degrada-
tion. Separating the TPR and U-box domains in CHIP is
a central domain rich in charged residues and also con-
taining 2 possible nuclear localizing signals. The function
of CHIP’s charged domain is not yet known, although it
is necessary for TPR-dependent interactions (Ballinger et
al 1999). Comparison of the amino acid sequence of CHIP
across species indicates that human CHIP shares 98%
amino acid similarity with mouse and 60% similarity
with Drosophila (Ballinger et al 1999). Strikingly, the
most highly conserved region is in the 94 residues at the
carboxyl terminus, the U-box domain, with 87% similar-
ity among these species (Ballinger et al 1999).
The messenger ribonucleic acid (mRNA) tissue distri-
bution of CHIP by Northern blot analysis supports the
notion that it participates in protein folding and degra-
dation decisions, because it is most highly expressed in
tissues with high metabolic activity and protein turnover:
skeletal muscle, heart, and brain. Although it is also pre-
sent in all other organs, including pancreas, lung, liver,
placenta, and kidney, the expression levels are much low-
er. CHIP mRNA can also be detected in most cell lines
and in primary cell cultures (Ballinger et al 1999). Intra-
cellularly, CHIP is primarily localized to the cytoplasm
under quiescent conditions (Ballinger et al 1999), al-
though a fraction of CHIP is present in the nucleus (Mea-
cham et al 2001). Our observations indicate that CHIP
may undergo intracellular trafficking in response to en-
vironmental challenge in cultured cells, the consequence
of which is not yet certain (McDonough and Patterson,
unpublished observations).
CHIP interactions with the molecular chaperones Hsc/
Hsp70 and Hsp90
Further characterization of CHIP led to the discovery that
CHIP is a bona fide interaction partner with the major
cytoplasmic chaperones Hsc70 and Hsp70, based on their
interactions with CHIP in a yeast 2-hybrid screen and in
vitro binding assays (Ballinger et al 1999). The binding
determinants required for CHIP’s interactions with Hsc70
have been mapped using glutathione S-transferase (GST)
fusion protein assays. The TPR domain and an adjacent
charged region of CHIP (amino terminus residues 1 to
197) are necessary for its interaction with Hsp70 and
Hsc70 (Ballinger et al 1999), and CHIP interacts with the
carboxy-terminal domain of Hsc70 (residues 540 to 650
of Hsc70), which is known to contain a TPR-acceptor site
that also interacts with the TPR domain-containing co-
chaperone HOP (Demand et al 1998).
Although the carboxy-terminal domain of the 70-kDa
heat shock proteins is the interaction domain for CHIP’s
amino terminal TPR domain, it is the amino terminal
ATP-binding domain of Hsp70-Hsc70 that regulates sub-
strate binding in a nucleotide-dependent fashion. The mo-
lecular cochaperones Hip and Hsp40 promote substrate
binding by stabilizing the adenosine diphosphate (ADP)-
bound conformation and activating ATPase activity, re-
spectively (Hohfeld et al 1995; Minami et al 1996), where-
as BAG-1 promotes substrate release by exchanging ATP
for ADP (Hohfeld and Jentsch 1997) (Fig 1). In contrast,
CHIP inhibits ATP hydrolysis and, therefore, attenuates
substrate binding and refolding, resulting in inhibition of
the ‘‘forward’’ Hsp70-Hsc70 substrate folding-refolding
pathway, at least in in vitro assays. The cellular conse-
quences of this ‘‘antichaperone’’ function are not yet clear.
This activity may provide a mechanism to slow the Hsc70
reaction cycle under stressful conditions, or it may assist
in ‘‘loading’’ misfolded proteins into the ubiquitin-pro-
teasome machinery, as described below.
Because Hsp90 also contains a TPR-acceptor site to in-
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teract with cochaperones, the possibility that CHIP might
also interact with Hsp90 has been entertained (although
seldom do TPR-containing proteins interact with both the
Hsp90 and Hsp70 family of chaperones). Indeed, CHIP
does interact with Hsp90 with approximately equivalent
affinity to its interactions with Hsp70 (Connell et al 2001).
This interaction results in remodeling of Hsp90 chaper-
one complexes, such that the cochaperone p23 (which is
required for the appropriate activation of several Hsp90-
dependent steroid receptors such as the glucocorticoid re-
ceptor [GR]) is excluded. The mechanism for this activity
is unclear—p23 and CHIP bind Hsp90 through different
sites—yet, the consequence of this action is predictable:
CHIP should inhibit the function of proteins that require
Hsp90 for conformational activation. The GR is an Hsp90
client that undergoes activation through a well-described
sequence of events that depend on interactions of the GR
with Hsp90 and various Hsp90 cochaperones, including
p23, making it an excellent model to test this prediction.
Indeed, CHIP inhibits GR substrate binding and steroid-
dependent transactivation ability. Surprisingly, this effect
of CHIP is accompanied by decreased steady-state levels
of GR, and CHIP induces ubiquitylation of the GR in vivo
and in vitro and proteasome-dependent degradation.
This effect is both U box– and TPR-domain dependent,
suggesting that CHIP’s effects on GR require direct in-
teraction with Hsp90 and direct ubiquitylation of GR and
delivery to the proteasome.
These observations are not limited to the GR. ErbB2,
another Hsp90 client, is also degraded by CHIP in a pro-
teasome-dependent fashion (Xu et al 2002). Nor are they
limited to Hsp90 clients; the cystic fibrosis transmem-
brane conductance receptor, an Hsp70 client, undergoes
CHIP-dependent degradation that is Hsp70 dependent
(Meacham et al 2001), and luciferase undergoes CHIP-
dependent ubiquitylation in vitro when it is misfolded
and bound by Hsp70 (Murata et al 2001). In each case,
the effects of CHIP are dependent on both the TPR do-
main, indicating a necessity for interactions with molec-
ular chaperones, and the U box, which suggests that the
U box is most likely the ‘‘business end’’ with respect to
ubiquitylation.
The means by which CHIP-dependent ubiquitylation
occurs is not clear. In the case of ErbB2, ubiquitylation
depends on a transfer of the client protein from Hsp90
to Hsp70 (Xu et al 2002), indicating that the final ubiqui-
tylation complex consists of CHIP, Hsp70 (but not
Hsp90), and the client protein. In any event, the studies
are consistent in supporting a role for CHIP as a key
component of the chaperone-dependent quality control
mechanism. CHIP efficiently targets client proteins, par-
ticularly when they are partially unfolded (as is the case
for most Hsp90 clients when bound to the chaperone) or
frankly misfolded (as is the case for most proteins bind-
ing to Hsp70 through exposed hydrophobic residues).
CHIP is a prototypical U box with ubiquitin ligase
activity
Once the ubiquitylation activity of CHIP was recognized,
it was logical to speculate that its U box might function
in a manner analogous to that of RING fingers, which
have been appreciated rather recently as key components
of the largest family of ubiquitin ligases. The ubiquity-
lation reaction in vivo requires, in addition to ubiquitin
itself: a ubiquitin-activating enzyme (or E1), which forms
a thiolester bond with ubiquitin at its carboxyl terminus;
a ubiquitin-conjugating enzyme (or E2), which accepts ac-
tivated ubiquitin from E1; and a ubiquitin ligase, or E3,
which forms a complex with E2 and substrate to catalyze
the transfer of ubiquitin residues, which generally are
added progressively to substrates until the multiubiquitin
chains are long enough to target the substrate to the pro-
teasome for degradation (Hershko and Ciechanover 1998;
Jackson et al 2000). If CHIP is a ubiquitin ligase, then its
ability to ubiquitylate a substrate should be reconstituted
in vitro, when a substrate is added in the presence of
CHIP, E1, an E2, and ubiquitin. Indeed, this is the case
(Jiang et al 2001; Murata et al 2001). CHIP is thus the first
described chaperone-associated E3 ligase. The ubiquitin
ligase activity of CHIP depends on functional and phys-
ical interactions with a specific family of E2 enzymes, the
UBC4/UBC5 family, which in humans comprises the E2s
UBCH5a, UBCH5b, and UBCH5c (Jiang et al 2001; Mur-
ata et al 2001). Of interest is the fact that the UBC4/UBC5
family of E2s is ‘‘stress-activated’’ ubiquitin-conjugating
enzymes (Seufert and Jentsch 1990). CHIP can therefore
be seen as a cochaperone that, in addition to inhibiting
traditional chaperone activity, converts chaperone com-
plexes into a chaperone-dependent ubiquitin ligase. Evi-
dence that CHIP directly identifies and associates with
misfolded proteins has not been forthcoming, thus the
most likely model (yet to be tested formally) is that the
chaperones themselves are the substrate-recognition com-
ponents of these ubiquitin ligase complexes, with the
chaperones functioning as ‘‘F-box equivalents,’’ analo-
gous to many RING finger-containing ubiquitin ligase
complexes that require an F-box-containing protein as the
substrate-recognition module (Jackson et al 2000; Jackson
and Eldridge 2002).
An escort to the proteasome
Although multiubiquitylation of substrates is the classic
signal for proteasome-dependent degradation, there still
remains the issue of how these substrates are transported
to the proteasome. Several lines of evidence suggest that
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CHIP participates in substrate ‘‘delivery’’ to the protea-
some: (1) CHIP interacts with the S5a proteasome subunit
in yeast 2-hybrid and GST pulldown assays, (2) the HC8
particle of the proteasome is detected in CHIP immuno-
precipitates in vivo, and (3) CHIP colocalizes with the
proteasome in cells treated with proteasome inhibitors
(Connell et al 2001; Meacham et al 2001). These data pro-
vide further support for the model that CHIP is a molec-
ular link between the cellular folding-refolding machin-
ery and the cellular degradation machinery and suggest
that CHIP may also participate in the transport of ubi-
quitylated proteins to the proteasome for their degrada-
tion.
Interestingly, the cochaperone BAG-1 has also been im-
plicated in transport to the proteasome (Luders et al
2000). BAG-1 associates with the proteasome through its
amino terminal ubiquitin-like domain and it binds to the
proteasome in an ATP-dependent manner (Luders et al
2000). In the case of CHIP, the mechanism of proteasome
association remains enigmatic but probably involves its
E3 ubiquitin ligase activity. In addition to catalyzing ubi-
quitylation of Hsp/Hsc70 and Hsp90 substrates, CHIP
also ubiquitylates Hsc70 with short noncanonical multiu-
biquitin chains and autoubiquitylates itself (Hatakeyama
et al 2001; Jiang et al 2001). The ubiquitylation of Hsc70
and of CHIP itself does not serve as a signal for degra-
dation (Jiang et al 2001). One possible function of such
noncanonical ubiquitylation may be to target Hsc70 and
CHIP, along with their cargo substrates, to the protea-
some. Interestingly BAG-1 and CHIP may function as
partners in delivering substrates to the proteasome. A di-
rect interaction between the 2 cochaperones is indicated
by the finding that BAG-1 and CHIP coprecipitate, and
the addition of Hsc70 increases the amount of CHIP in
these immunocomplexes (Demand et al 2001). Although
overexpression of BAG-1 alone does not increase the rate
of turnover of a model chaperone substrate (the GR),
coexpression of BAG-1 with CHIP does increase its deg-
radation, suggesting that the physical interaction between
BAG-1 and CHIP is cooperative with respect to targeting
chaperone substrates for degradation. The model sug-
gested by these studies is that the proteasome binding
activity of BAG-1 (through its ubiquitin-like domain) and
its stimulation of substrate release from Hsc/Hsp70 can
act in concert with CHIP’s ubiquitin ligase activity to de-
liver substrates to the proteasome such that they will be
recognized as marked for degradation (Demand et al
2001). Thus, cooperation between 2 Hsc/Hsp 70 molec-
ular cochaperones tilts the molecular folding-refolding
machinery toward the degradation pathway with CHIP’s
multiubiquitylation activity providing the rate-limiting
step.
Protein folding-degradation machinery and disease
The elucidation of CHIP’s roles in the cell has helped clar-
ify the mechanism of linkage between the cells protein
folding-refolding machinery and its degradation machin-
ery—the 2 pathways called upon to provide protein qual-
ity control in the cell and thereby maintain healthy cel-
lular function, particularly in the setting of cellular stress.
Characterization of CHIP function may therefore provide
insights into how the cellular processes contribute to
physiologic and pathologic processes at the cellular and
organismal level. Although a link with CHIP and path-
ophysiologic states is largely speculative at present, it is
worth considering how the basic observations of CHIP at
the level of biochemistry and cell biology can provide
clues to understanding human disease.
For example, further clarification of the factors that
push the protein quality control machinery down one
pathway or the other may help in understanding the pos-
sible failures in this system that result in the accumula-
tion of misfolded protein aggregates that are the signa-
ture of several degenerative disease states, such as the
Lewy bodies in Parkinson disease, the neurofibrillary tan-
gles in Alzheimer disease, and the ubiquitin-positive in-
clusions in polyglutamine-repeat diseases. In fact, recent
data provide a direct link between CHIP and the patho-
physiology of Parkinson disease. In juvenile Parkinson
disease, mutations in the Parkin gene result in loss of do-
paminergic neurons and the consequent motor deficits as-
sociated with Parkinson disease. Parkin is a RING finger
E3 ubiquitin ligase, and PaelR (the membrane receptor for
Pael) is 1 well-characterized substrate for its E3 activity.
The accumulation of PaelR when Parkin is mutated is
thought to contribute to the pathology of Parkinson dis-
ease. The degradation of unfolded PaelR by Parkin re-
quires the participation of CHIP. CHIP promotes release
of PaelR from Hsc/Hsp 70, and only upon this release
can Parkin act as a ubiquitin ligase to signal PaelR deg-
radation (Imai et al 2002). Although it is not entirely clear
from the biochemical data available how the respective
ubiquitin ligase activities of CHIP and Parkin cooperate
to trigger ubiquitylation of substrates in this context, the
2 proteins have cooperative effects in protection against
neuronal cell death. In any event, these results indicate
that CHIP has a direct role in a particular protein quality
control pathway that results in a neurodegenerative dis-
ease when it is impaired.
As a key player in eliminating damaged or unneeded
proteins, one can imagine that CHIP may also have pro-
tective functions in other cell types and organs that are
susceptible to chronic stress. For example, the high levels
of CHIP expressed in the heart (Ballinger et al 1999) may
reflect the ‘‘wear and tear’’ on cardiac tissue that is con-
stant and for which protein turnover and degradation is
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a continual requirement. The pathology of alphaB crys-
tallin accumulation is a case in point. Specific mutations
in the alphaB crystallin gene result in its misfolding,
which overwhelms chaperone activity within cardiomy-
ocytes leading to accumulation within the cell and a di-
lated cardiomyopathy. Congestive heart failure and lethal
arrhythmias are the consequence of accumulation of
alphaB crystallin deposits (Vicart et al 1998). This is one
obvious example of how failure of protein quality control
leads to cardiac dysfunction. It will be interesting to de-
termine whether this is a more general mechanism of car-
diac dysfunction, and the extent to which proteins such
as CHIP may play a protective role in this setting.
Beyond its function of eliminating damaged proteins,
CHIP’s ubiquitylating activity could also serve to mark
proteins for degradation because they are no longer need-
ed for a specific cellular function, such as a signaling
event. The identification of the signaling molecule ErbB2
as a CHIP substrate provides an example of this type of
regulation (Xu et al 2002). ErbB2 overexpression is linked
to an aggressive outcome in human breast cancers, and
strategies to target ErbB2 degradation through activation
of chaperone-dependent pathways involving CHIP may
have therapeutic potential (Citri et al 2002). These obser-
vations should inspire further work linking CHIP sub-
strates with specific cellular functions in situations where
chaperone-dependent protein degradation plays a critical
role.
Summary
As our understanding of the biochemistry of molecular
chaperones and cochaperones improves, the mechanisms
of their involvement in protein homeostasis and in path-
ways that promote and protect cellular health will serve
to present potential points of intervention to prevent or
improve diseased states. CHIP, as a cochaperone linking
the folding-refolding and degradation pathways and as a
potential cellular stress capacitor, could prove to be a piv-
otal player in these processes.
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2001. CHIP is a U-box-dependent E3 ubiquitin ligase: identifi-
cation of Hsc70 as a target for ubiquitylation. J Biol Chem 276:
42938–42944.
Lamb JR, Tugendreich S, Hieter P. 1995. Tetratrico peptide repeat
interactions: to TPR or not to TPR? Trends Biochem Sci 20: 257–
259.
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Minami Y, Höhfeld J, Ohtsuka K, Hartl FU. 1996. Regulation of the
heat-shock protein 70 reaction cycle by the mammalian DnaJ
homolog, Hsp40. J Biol Chem 271: 19617–19624.
Murata S, Minami Y, Minami M, Chiba T, Tanaka K. 2001. CHIP is
a chaperone-dependent E3 ligase that ubiquitylates unfolded
protein. EMBO Reports 2: 1133–1138.
Ratajczak T, Carrello A, Mark PJ, Warner BJ, Simpson RJ, Moritz RL,
House AK. 1993. The cyclophilin component of the unactivated
estrogen receptor contains a tetratricopeptide repeat domain
and shares identity with p59 (FKBP59). J Biol Chem 268: 13187–
13192.
Seufert W, Jentsch S. 1990. Ubiquitin-conjugated enzymes UBC4 and
Cell Stress & Chaperones (2003) 8 (4), 303–308
308 McDonough and Patterson
UBC5 mediate selective degradation of short-lived and abnor-
mal proteins. EMBO J 9: 543–550.
Vicart P, Caron A, Guicheney P, et al. 1998. A missense mutation in
the alphaB-crystallin chaperone gene causes a desmin-related
myopathy. Nat Genet 20: 92–95.
Wickner S, Maurizi M, Gottesman S. 1999. Posttranslational quality
control: folding, refolding and degrading proteins. Science 286:
1888–1893.
Xu W, Marcu M, Yuan X, Mimnaugh E, Patterson C, Neckers L. 2002.
Chaperone-dependent E3 ubiquitin ligase CHIP mediates a
degradative pathway for c-ErbB2/Neu. Proc Natl Acad Sci U S
A 99: 12847–12852.
